Beta Drugs (India) Price Prediction
| BETA Stock | 2,072 52.20 2.58% |
Oversold Vs Overbought
54
Oversold | Overbought |
Using Beta Drugs hype-based prediction, you can estimate the value of Beta Drugs from the perspective of Beta Drugs response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Beta Drugs to buy its stock at a price that has no basis in reality. In that case, they are not buying Beta because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Beta Drugs after-hype prediction price | INR 2083.6 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Beta |
Beta Drugs Estimiated After-Hype Price Prediction Volatility
As far as predicting the price of Beta Drugs at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Beta Drugs or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Beta Drugs, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Beta Drugs Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Beta Drugs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Beta Drugs backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Beta Drugs, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.41 | 3.21 | 11.40 | 2.60 | 2 Events / Month | 1 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2,072 | 2,084 | 0.55 |
|
Beta Drugs Hype Timeline
Beta Drugs is currently traded for 2,072on National Stock Exchange of India of India. The entity has historical hype elasticity of 11.4, and average elasticity to hype of competition of 2.6. Beta is projected to increase in value after the next headline, with the price projected to jump to 2083.6 or above. The average volatility of media hype impact on the company the price is about 11.55%. The price appreciation on the next news is projected to be 0.55%, whereas the daily expected return is currently at 0.41%. The volatility of related hype on Beta Drugs is about 50.55%, with the expected price after the next announcement by competition of 2,075. Assuming the 90 days trading horizon the next projected press release will be in a few days. Check out Beta Drugs Basic Forecasting Models to cross-verify your projections.Beta Drugs Related Hype Analysis
Having access to credible news sources related to Beta Drugs' direct competition is more important than ever and may enhance your ability to predict Beta Drugs' future price movements. Getting to know how Beta Drugs' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Beta Drugs may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RELIANCE | Reliance Industries Limited | 21.15 | 5 per month | 0.00 | (0.25) | 1.68 | (2.07) | 5.51 | |
| TCS | Tata Consultancy Services | 27.95 | 4 per month | 0.00 | (0.05) | 1.66 | (2.02) | 7.29 | |
| HDFCBANK | HDFC Bank Limited | 8.25 | 3 per month | 1.17 | 0 | 2.25 | (2.14) | 5.51 | |
| BHARTIARTL | Bharti Airtel Limited | (31.95) | 6 per month | 0.00 | (0.12) | 1.97 | (1.95) | 7.26 |
Beta Drugs Additional Predictive Modules
Most predictive techniques to examine Beta price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Beta using various technical indicators. When you analyze Beta charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Beta Drugs Predictive Indicators
The successful prediction of Beta Drugs stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Beta Drugs, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Beta Drugs based on analysis of Beta Drugs hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Beta Drugs's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Beta Drugs's related companies.
Story Coverage note for Beta Drugs
The number of cover stories for Beta Drugs depends on current market conditions and Beta Drugs' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Beta Drugs is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Beta Drugs' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Tools for Beta Stock Analysis
When running Beta Drugs' price analysis, check to measure Beta Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beta Drugs is operating at the current time. Most of Beta Drugs' value examination focuses on studying past and present price action to predict the probability of Beta Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beta Drugs' price. Additionally, you may evaluate how the addition of Beta Drugs to your portfolios can decrease your overall portfolio volatility.